NFIB and adrenal cortex carcinoma: DNA damage repair (DDR) genes are mutated in fusion-positive patients; however, one wild-type patient also demonstrated a mutation in ARID1A. The significance of MYB-NFIB gene fusion on the genomic profile of ACC patients is highlighted.